Back to search results

Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Gastrointestinal Stromal Tumor (GIST) · C-KIT Mutation · Advanced Gastrointestinal Stromal Tumor (GIST)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • CHU Besançon, Besançon, France

    Contact: Study coordinator (Elsa KALBACHER, MD) · ekalbacher@chu-besancon.fr · 03.70.63.24.03
    Contact: Principal Investigator (Elsa KALBACHER, MD)
    Loïc CHAIGNEAU, MD (Sub-investigator)
    Guillaume MEYNARD, MD (Sub-investigator)

  • Institut Bergonié, Bordeaux, France

    Contact: Study coordinator (Antoine ITALIANO) · A.Italiano@bordeaux.unicancer.fr
    Contact: Principal Investigator (Antoine ITALIANO)
    Maud TOULMONDE (Sub-investigator)
    Kevin BOURCIER (Sub-investigator)
    Sophie COUSIN (Sub-investigator)

  • CHU Dupuytren, Limoges, France

    Contact: Study coordinator (Valérie LE BRUN LY, MD) · valerie.lebrunly@chu-limoges.fr

  • Centre Léon Bérard, Lyon, France

    Contact: Study coordinator (Jean-Yves BLAY, PhD)
    Study coordinator · jean-yves.blay@lyon.unicancer.fr · 04 78 78 27 57
    Contact: Principal Investigator (Jean-Yves BLAY, PhD)
    Mehdi BRAHMI (Sub-investigator)
    Armelle DUFRESNE (Sub-investigator)
    Isabelle RAY-COQUARD (Sub-investigator)

  • Institut Paoli Calmettes, Marseille, France

    Contact: Study coordinator (François BERTUCCI, PhD) · bertuccif@ipc.unicancer.fr
    Contact: Principal Investigator (François BERTUCCI, PhD)
    Audrey MONNEUR (Sub-investigator)
    Elika LOIR (Sub-investigator)
    Simon LAUNAY (Sub-investigator)
    Frédéric VIRET (Sub-investigator)
    Brice CHANEZ (Sub-investigator)
    Delphine LOUVEL PERROT (Sub-investigator)

  • Institut Curie, Paris, France

    Contact: Study coordinator (Sophie PIPERNO NEUMANN) · sophie.piperno-neumann@curie.fr
    Contact: Principal Investigator (Sophie PIPERNO NEUMANN)

  • CHU de Reims, Reims, France

    Contact: Study coordinator (Olivier BOUCHE, PhD)
    Contact: Principal Investigator (Olivier BOUCHE, PhD)
    Mathilde BRASSEUR, MD (Sub-investigator)
    Damien BOTSEN, MD (Sub-investigator)

  • Centre Eugène Marquis, Rennes, France

    Christophe PERRIN, MD (Sub-investigator)
    Contact: Principal Investigator (Marc PRACHT, MD)
    Angélique BRUNOT, MD (Sub-investigator)
    Astrid LIEVRE, PhD (Sub-investigator)
    Eugénie RIGAULT, MD (Sub-investigator)
    Thomas GRAINVILLE, MD (Sub-investigator)
    Anne-Sophie MOUSSADDAQ, MD (Sub-investigator)

  • Institut de Cancérologie de l'Ouest - Site Réné Gauducheau, Saint-Herblain, France

    Contact: Study coordinator (Emanuelle BOMPAS)
    Contact: Principal Investigator (Emanuelle BOMPAS)
    Fréderic ROLLAND (Sub-investigator)
    Damien VANSTEENE (Sub-investigator)

  • Institut de Cancérologie Lucien NEUWIRTH, Saint-Paul-en-Jarez, France

    Contact: Study coordinator (Olivier COLLARD, MD) · Olivier.COLLARD@icloire.fr
    Contact: Principal Investigator (Olivier COLLARD, MD)
    Cécile VASSAL, MD (Sub-investigator)

  • Institut Claudius Regaud, Toulouse, France

    Contact: Study coordinator (Valentin THIBAUD) · valentin.Thibaud@iuct-oncopole.fr
    Contact: Principal Investigator (Valentin THIBAUD)
    Iphigénie KORAKIS (Sub-investigator)
    Christine CHEVREAU (Sub-investigator)

  • Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France

    Contact: Study coordinator (Maria RIOS, MD)
    Contact: Principal Investigator (Maria RIOS, MD)

  • Institut Goustave Roussy, Villejuif, France

    Contact: Study coordinator (Axel LE CESNE, PhD) · axel.lecesne@gustaveroussy.fr · 01 42 11 43 16
    Contact: Principal Investigator (Axel LE CESNE, PhD)
    Rastislav BAHLEDA, MD (Sub-investigator)
    Olivier MIR, MD (Sub-investigator)
    Benjamin VERRET, MD (Sub-investigator)
Study leads

  • Jean-Yves BLAY, Pr

    Principal Investigator

    Centre Léon Bérard, Lyon

View source on ClinicalTrials.gov(opens in a new tab)